mAChR Inhibitors

mAChR1

mAChR2

mAChR3

mAChR4

mAChR5

mAChR Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	mAChR1	mAChR2	mAChR3	mAChR4	mAChR5	Purity
Clozapine N-oxide			mAChR3	mAChR4		99.98%
Deschloroclozapine			mAChR3	mAChR4		99.93%
Pilocarpine Hydrochloride			mAChR3			99.98%
Clozapine N-oxide dihydrochloride			mAChR3	mAChR4		99.74%
Atropine				mAChR4		99.85%
Pilocarpine			mAChR3			99.89%
Clozapine	mAChR1, Ki: 9.5 nM (Antagonist)			mAChR4, EC₅₀: 11 nM (Agonist)		99.84%
Xanomeline	mAChR1			mAChR4		99.84%
Methacholine chloride			mAChR3			≥98.0%
Darifenacin hydrobromide			mAChR3			99.78%
Darifenacin			mAChR3			99.81%
Tiotropium Bromide	mAChR1	mAChR2	mAChR3			99.91%
Atropine sulfate				mAChR4		99.87%
(S)-(+)-Dimethindene maleate	mAChR1, pKi: 7.08	mAChR2, pKi: 7.78	mAChR3, pKi: 6.70	mAChR4, pKi: 7.00		99.80%
4-DAMP			mAChR3		mAChR5	99.96%
Iperoxo	mAChR1, pEC₅₀: 9.87	mAChR2, pEC₅₀: 10.1	mAChR3, pEC₅₀: 9.78			99.48%
Bethanechol chloride	mAChR1		mAChR3	mAChR4	mAChR5	99.56%
Cevimeline hydrochloride	mAChR1		mAChR3			98.74%
DREADD agonist 21			mAChR3			99.46%
DREADD agonist 21 dihydrochloride			mAChR3			98.94%
VU 0255035	mAChR1					99.76%
Otenzepad		mAChR2				99.93%
Pilocarpine nitrate			mAChR3			99.83%
Trospium chloride	mAChR1	mAChR2	mAChR3			99.93%
Fesoterodine fumarate	mAChR1		mAChR3	mAChR4	mAChR5	99.52%
Pirenzepine dihydrochloride	mAChR1					99.84%
Oxotremorine sesquifumarate		mAChR2				98.0%
Atropine sulfate monohydrate				mAChR4		99.87%
Tropicamide				mAChR4		98.87%
TAK-071	mAChR1					99.44%
Cevimeline hydrochloride hemihydrate	mAChR1		mAChR3			99.52%
Ipratropium bromide	mAChR1	mAChR2	mAChR3			99.92%
MK-7622	mAChR1					99.80%
VU6019650					mAChR5, IC₅₀: 36 nM	99.83%
VU0467154				mAChR4		99.23%
Diphenidol hydrochloride	mAChR1	mAChR2	mAChR3	mAChR4		99.06%
Aceclidine	mAChR1		mAChR3			99.23%
VU0453595	mAChR1					99.90%
JHU37160			mAChR3	mAChR4		99.98%
Solifenacin	mAChR1	mAChR2	mAChR3			99.77%
Sabcomeline hydrochloride	mAChR1, pKi: 6.72		mAChR3, pKi: 7.03	mAChR4, pKi: 7.23	mAChR5, pKi: 7.14	99.81%
Methoctramine tetrahydrochloride		mAChR2				98.72%
Smilagenin	mAChR1					98.0%
(Rac)-5-Hydroxymethyl Tolterodine	mAChR1		mAChR3	mAChR4	mAChR5	99.05%
VU0357017 hydrochloride	mAChR1					98.63%
Umeclidinium bromide	mAChR1				mAChR5	99.72%
N-Desmethylclozapine	mAChR1					99.10%
LY2119620		mAChR2		mAChR4		99.74%
ML375					mAChR5	99.64%
ASP8302			mAChR3			98.95%
McN-A-343	mAChR1					99.89%
PD 102807				mAChR4		98.52%
Biperiden hydrochloride	mAChR1					99.90%
Telenzepine dihydrochloride	mAChR1					99.57%
Fesoterodine L-mandelate	mAChR1		mAChR3	mAChR4	mAChR5	98.92%
Clozapine (Standard)	mAChR1			mAChR4
Imidafenacin	mAChR1		mAChR3			99.26%
Scopolamine butylbromide		mAChR2, Ki: 83 (rats) nM	mAChR3, Ki: 290 (rats) nM			99.97%
Batefenterol		mAChR2	mAChR3			99.72%
VU0364572 TFA	mAChR1, EC₅₀: 0.11 μM					98.79%
Dicyclomine hydrochloride	mAChR1	mAChR2				98.09%
Fesoterodine	mAChR1		mAChR3	mAChR4	mAChR5	99.61%
VU0467319	mAChR1, EC₅₀: 492 nM					98.53%
Sofpironium bromide			mAChR3	mAChR4	mAChR5	98.26%
VU6028418				mAChR4		99.52%
Solifenacin Succinate	mAChR1	mAChR2	mAChR3			99.91%
Atropine (Standard)				mAChR4
VU 0238429					mAChR5	99.96%
Tiotropium bromide monohydrate	mAChR1	mAChR2	mAChR3			99.68%
Solifenacin hydrochloride	mAChR1	mAChR2	mAChR3			98.86%
Ipratropium bromide hydrate	mAChR1, IC₅₀: 2.9 nM	mAChR2, IC₅₀: 2 nM	mAChR3, IC₅₀: 1.7 nM			99.90%
JHU37152			mAChR3	mAChR4		99.45%
VU0119498	mAChR1		mAChR3		mAChR5	98.76%
HY-078020			mAChR3			98.87%
PCS1055 dihydrochloride				mAChR4		98.88%
TBPB	mAChR1, EC₅₀: 289 nM					99.74%
Penehyclidine hydrochloride	mAChR1		mAChR3			99.2%
Talsaclidine		mAChR2	mAChR3			98.75%
AC260584	mAChR1					99.48%
Tarafenacin D-tartrate			mAChR3, Ki: 0.19 nM			99.86%
VU 0365114					mAChR5	99.41%
Olanzapine-d₃	mAChR1					99.78%
VU 6008667					mAChR5	99.53%
VU0467485				mAChR4		99.29%
PCS1055				mAChR4, IC₅₀: 18.1 nM mAChR4, Kd: 5.72 nM		98.02%
Clozapine hydrochloride	mAChR1, Ki: 9.5 nM			mAChR4, EC₅₀: 11 nM		99.83%
Cevimeline	mAChR1		mAChR3			99.88%
VU0152100				mAChR4		98.98%
Isopteropodine	mAChR1					99.13%
Hexocyclium methylsulfate	mAChR1, pKi: 8.9	mAChR2, pKi: 7.7	mAChR3, pKi: 8.4	mAChR4, pKi: 8.8		99.93%
VU6004256	mAChR1, EC₅₀: 155 nM					99.61%
Aceclidine hydrochloride	mAChR1		mAChR3			98.0%
VU0448088				mAChR4, EC₅₀: 56 nM		98.67%
VU6008055				mAChR4, EC₅₀: 73.4 nM		99.43%
Direclidine				mAChR4
(Rac)-VU 6008667					mAChR5	99.85%
(Rac)-5-Hydroxymethyl Tolterodine hydrochloride	mAChR1		mAChR3	mAChR4	mAChR5
Ipratropium-d₃ bromide	mAChR1	mAChR2	mAChR3			98.0%
VU10010				mAChR4		98.04%
mAChR antagonist 1	mAChR1, Ki: 255 nM	mAChR2, Ki: >1000 nM	mAChR3, Ki: 121 nM	mAChR4, Ki: 158 nM	mAChR5, Ki: 255 nM	99.59%
p-F-HHSiD hydrochloride	mAChR1	mAChR2	mAChR3	mAChR4	mAChR5	99.0%
PDE4-IN-4			mAChR3
VLVNTFCDSCIPKTYWNLGY TFA			mAChR3
Nebracetam hydrochloride	mAChR1					99.0%
Trospium-d₈ chloride	mAChR1	mAChR2	mAChR3
Alvameline			mAChR3
4-Piperidyl N-(2-biphenyl)carbamate		mAChR2, pKi: 7.33	mAChR3, pKi: 7.51			99.97%
Bethanechol	mAChR1		mAChR3	mAChR4	mAChR5
Tarafenacin			mAChR3, Ki: 0.19 nM
YM-58790	mAChR1, Ki: 28 nM	mAChR2, Ki: 260 nM	mAChR3, Ki: 15 nM			98.21%
Penehyclidine	mAChR1		mAChR3
(Rac)-5-Hydroxymethyl Tolterodine-d₁₄	mAChR1		mAChR3	mAChR4	mAChR5
rel-Biperiden EP impurity A-d₅	mAChR1
VU6002703				mAChR4, EC₅₀: 0.6 μM
Solifenacin D5 hydrochloride	mAChR1	mAChR2	mAChR3
Milameline hydrochloride	mAChR1, IC₅₀: 1.3 μM	mAChR2, IC₅₀: 1.1 μM	mAChR3, IC₅₀: 1.5 μM	mAChR4, IC₅₀: 1.9 μM
M1/M4 muscarinic agonist 1	mAChR1, EC₅₀: 55 nM			mAChR4, EC₅₀: 14 nM
Vedaclidine	mAChR1	mAChR2	mAChR3	mAChR4	mAChR5
VU6052254	mAChR1, EC₅₀: 59 nM
N-Desmethylclozapine-d₈	mAChR1					98.73%
Lu AE51090	mAChR1, EC₅₀: 61 nM	mAChR2, Ki: 2200 nM	mAChR3, Ki: 7000 nM	mAChR4, Ki: 6900 nM	mAChR5, Ki: 8900 nM	99.51%
Pilocarpine-d₃ hydrochloride			mAChR3
Solifenacin-d₅ succinate	mAChR1	mAChR2	mAChR3
M1 mAChR modulator-1	mAChR1
YM-58790 free base	mAChR1, Ki: 28 nM	mAChR2, Ki: 260 nM	mAChR3, Ki: 15 nM
VU0415248	mAChR1
VU0476406				mAChR4, EC₅₀: 91 nM mAChR4, pEC₅₀: 7.04
VU6009453				mAChR4, EC₅₀: 383 nM
Pirenzepine-d₈	mAChR1
PTAC oxalate	mAChR1, Ki: 0.6 nM	mAChR2, Ki: 2.8 nM	mAChR3, Ki: 0.2 nM	mAChR4, Ki: 0.2 nM	mAChR5, Ki: 0.8 nM
M4 mAChR Modulator-2				mAChR4, EC₅₀: 513 nM mAChR4, Ki: 377 nM
(±)-Darifenacin-d₄ hydrobromide			mAChR3
Muscarinic M4 modulator-1				mAChR4
LAS190792	mAChR1, pIC₅₀: 8.9	mAChR2, pIC₅₀: 8.8	mAChR3, pIC₅₀: 8.8	mAChR4, pIC₅₀: 9.2	mAChR5, pIC₅₀: 8.2
DIBA-Cy5	mAChR1, Kd: 104.5 nM	mAChR2, Kd: 1.80 nM
Milameline	mAChR1, IC₅₀: 1.3 μM	mAChR2, IC₅₀: 1.1 μM	mAChR3, IC₅₀: 1.5 μM	mAChR4, IC₅₀: 1.9 μM
Atropine hydrobromide				mAChR4
M4 mAChR Modulator-1				mAChR4
Lu 26-046	mAChR1, Ki: 0.51 nM	mAChR2, Ki: 26 nM	mAChR3, Ki: 5 nM
Nebracetam	mAChR1
VU6015241				mAChR4, Ki: 43.3 nM
5-Hydroxymethyl Tolterodine-d₁₄ formate	mAChR1		mAChR3	mAChR4	mAChR5
M1 ligand 1	mAChR1
J 104129 fumarate		mAChR2, Ki: 490 nM	mAChR3, Ki: 4.2 nM
Umeclidinium-d₅ bromide	mAChR1				mAChR5
Bethanechol-d₆ chloride	mAChR1		mAChR3	mAChR4	mAChR5
VU6009048				mAChR4
Gallamine		mAChR2, EC₅₀: 130 nM
Isopteropodine (Standard)	mAChR1
L 689660 maleate	mAChR1		mAChR3
rel-Biperiden EP impurity B-d₅	mAChR1
Milameline hydroiodide	mAChR1, IC₅₀: 1.3 μM	mAChR2, IC₅₀: 1.1 μM	mAChR3, IC₅₀: 1.5 μM	mAChR4, IC₅₀: 1.9 μM
Diphenidol	mAChR1	mAChR2	mAChR3	mAChR4
Dicyclomine	mAChR1	mAChR2
Solifenacin-d₇ hydrochloride	mAChR1	mAChR2	mAChR3
Biperiden-d₅ hydrochloride	mAChR1
Clozapine dihydrochloride	mAChR1, Ki: 9.5 nM			mAChR4, EC₅₀: 11 nM
A-72055	mAChR1, Ki: 32 nM	mAChR2, Ki: 30 nM
(±)-Darifenacin-d₄			mAChR3
Umeclidinium-d₁₀ bromide	mAChR1				mAChR5
MHP 133	mAChR1	mAChR2
Navafenterol			mAChR3
M1/M2/M4 muscarinic agonist 1	mAChR1, EC₅₀: 26 nM	mAChR2, EC₅₀: 210 nM		mAChR4, EC₅₀: 6.5 nM
M3 mAChR agonist 1			mAChR3		mAChR5
PSD-506		mAChR2	mAChR3
PF-06764427	mAChR1
CHF-6550			mAChR3, pKi: 9.3
p-F-HHSiD	mAChR1	mAChR2	mAChR3	mAChR4	mAChR5
Darifenacin hydrobromide (Standard)			mAChR3
TAAR1 agonist 2		mAChR2, pEC₅₀: 5
Navafenterol saccharinate			mAChR3
rel-Biperiden-d₅	mAChR1
Sofpironium tosylate	mAChR1	mAChR2	mAChR3	mAChR4	mAChR5
Trihexyphenidyl-d₅ (hydrochloride)	mAChR1
PF-3635659			mAChR3
Ipratropium-d₇ bromide	mAChR1	mAChR2	mAChR3
AE9C90CB	mAChR1, pKi: 9.7	mAChR2, pKi: 8.6	mAChR3, pKi: 9.9	mAChR4, pKi: 9.5	mAChR5, pKi: 9.5
Revatropate	mAChR1	mAChR2	mAChR3
Atropine oxide hydrochloride	mAChR1	mAChR2	mAChR3	mAChR4	mAChR5
rac-Fesoterodine-d₁₄ fumarate	mAChR1		mAChR3	mAChR4	mAChR5
Arecaidine-propargyl ester	mAChR1, pKi: 5.91	mAChR2, pKi: 7.06	mAChR3, pKi: 6.07	mAChR4, pKi: 6.01	mAChR5, pKi: 6.03
Scotanamine D	mAChR1, IC₅₀: 32 nM
Rispenzepine	mAChR1		mAChR3
(1R,3S-)Solifenacin-d₅ hydrochloride	mAChR1	mAChR2	mAChR3
NPC-14695	mAChR1, Kd: 25 nM	mAChR2, Kd: 60 nM	mAChR3, Kd: 15 nM

Name
Email *

	Sorry, but the email address you supplied was invalid.